Free Trial

IceCure Medical (ICCM) Stock Price, News & Analysis

IceCure Medical logo
$1.19 +0.20 (+20.80%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$1.18 0.00 (-0.42%)
As of 08/28/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About IceCure Medical Stock (NASDAQ:ICCM)

Key Stats

Today's Range
$1.15
$1.31
50-Day Range
$0.79
$1.19
52-Week Range
$0.48
$1.66
Volume
17.21 million shs
Average Volume
951,209 shs
Market Capitalization
$69.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.39
Consensus Rating
Buy

Company Overview

IceCure Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

ICCM MarketRank™: 

IceCure Medical scored higher than 47% of companies evaluated by MarketBeat, and ranked 720th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    IceCure Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    IceCure Medical has only been the subject of 3 research reports in the past 90 days.

  • Read more about IceCure Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for IceCure Medical are expected to grow in the coming year, from ($0.28) to ($0.25) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of IceCure Medical is -7.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of IceCure Medical is -7.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    IceCure Medical has a P/B Ratio of 23.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    5.07% of the float of IceCure Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    IceCure Medical has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IceCure Medical has recently increased by 393.86%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    IceCure Medical does not currently pay a dividend.

  • Dividend Growth

    IceCure Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.07% of the float of IceCure Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    IceCure Medical has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IceCure Medical has recently increased by 393.86%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    IceCure Medical has a news sentiment score of 1.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for IceCure Medical this week, compared to 2 articles on an average week.
  • Search Interest

    19 people have searched for ICCM on MarketBeat in the last 30 days. This is an increase of 1,800% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added IceCure Medical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, IceCure Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.44% of the stock of IceCure Medical is held by insiders.

  • Percentage Held by Institutions

    Only 0.62% of the stock of IceCure Medical is held by institutions.

  • Read more about IceCure Medical's insider trading history.
Receive ICCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ICCM Stock News Headlines

FY2025 EPS Forecast for IceCure Medical Decreased by Analyst
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).tc pixel
See More Headlines

ICCM Stock Analysis - Frequently Asked Questions

IceCure Medical's stock was trading at $1.10 at the beginning of 2025. Since then, ICCM stock has increased by 8.2% and is now trading at $1.19.

IceCure Medical Ltd. (NASDAQ:ICCM) posted its earnings results on Wednesday, August, 13th. The company reported $0.06 EPS for the quarter, beating the consensus estimate of ($0.06) by $0.12. The company earned $0.66 million during the quarter, compared to analysts' expectations of $0.90 million. IceCure Medical had a negative trailing twelve-month return on equity of 136.96% and a negative net margin of 317.62%.
Read the conference call transcript
.

Shares of ICCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IceCure Medical investors own include Medical Properties Trust (MPW), Realty Income (O), Oxford Square Capital (OXSQ), PayPal (PYPL), A.P. Moller-Maersk (AMKBY), Annaly Capital Management (NLY) and Oxford Lane Capital (OXLC).

Company Calendar

Last Earnings
8/13/2025
Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:ICCM
CIK
1584371
Employees
60
Year Founded
N/A

Price Target and Rating

High Price Target
$2.77
Low Price Target
$2.00
Potential Upside/Downside
+100.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.32 million
Net Margins
-317.62%
Pretax Margin
-465.45%
Return on Equity
-136.96%
Return on Assets
-71.46%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
1.18
Quick Ratio
0.88

Sales & Book Value

Annual Sales
$3.29 million
Price / Sales
21.23
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.05 per share
Price / Book
23.80

Miscellaneous

Outstanding Shares
58,700,000
Free Float
57,265,000
Market Cap
$69.85 million
Optionable
Not Optionable
Beta
0.32

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:ICCM) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners